Literature DB >> 22744353

Radiofrequency ablation for single lung tumours not suitable for surgery: seven years' experience.

G Carrafiello1, M Mangini, F Fontana, D Laganà, E Cotta, A Di Massa, F Piacentino, A Ianniello, C Floridi, A M Ierardi, C Fugazzola.   

Abstract

PURPOSE: This study was done to review recurrence patterns in patients with lung cancer (primary or secondary) treated with percutaneous image-guided radiofrequency (RF) ablation.
MATERIALS AND METHODS: From January 2003 to August 2010, 32 patients (24 with primary non-small-cell lung cancer and eight with metastases) with single lung cancer were treated with RF ablation. Post-treatment imaging results were available for each patient. Follow-up was performed using computed tomography (CT) scans at 1, 3, 6, 12, 18 and 24 months after the procedure and annually thereafter. Patterns of recurrence were classified as local, intrapulmonary, nodal, mixed and distant. We evaluated overall survival after RF ablation and the factors associated with recurrence.
RESULTS: Seventeen (53.1%) patients showed no evidence of recurrence at follow-up imaging (range 12-72 months; mean, 32.5 months). Recurrence was seen in 15 (46.9 %) patients (range 6-36 months; mean 14.8 months). Local recurrence (40%) after RF ablation was the most frequent. Median disease-free survival was 20 months. Sex, tumour location, tumour size and tumour stage were not associated with a risk of recurrence. Patient age was related to the risk of recurrence (p<0.05).
CONCLUSIONS: Local recurrence is the most common pattern in our series. A more aggressive initial RF ablation might offer improvement in outcomes, but this hypothesis needs to be confirmed by larger studies involving a larger number of patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22744353     DOI: 10.1007/s11547-012-0849-z

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  26 in total

1.  New Response Evaluation Criteria in Solid Tumors (RECIST) guidelines for advanced non-small cell lung cancer: comparison with original RECIST and impact on assessment of tumor response to targeted therapy.

Authors:  Mizuki Nishino; David M Jackman; Hiroto Hatabu; Beow Y Yeap; Leigh-Anne Cioffredi; Jeffrey T Yap; Pasi A Jänne; Bruce E Johnson; Annick D Van den Abbeele
Journal:  AJR Am J Roentgenol       Date:  2010-09       Impact factor: 3.959

Review 2.  Image-guided tumor ablation: standardization of terminology and reporting criteria.

Authors:  S Nahum Goldberg; Clement J Grassi; John F Cardella; J William Charboneau; Gerald D Dodd; Damian E Dupuy; Debra Gervais; Alice R Gillams; Robert A Kane; Fred T Lee; Tito Livraghi; John McGahan; David A Phillips; Hyunchul Rhim; Stuart G Silverman
Journal:  Radiology       Date:  2005-04-21       Impact factor: 11.105

3.  Microwave ablation therapy for treating primary and secondary lung tumours: technical note.

Authors:  G Carrafiello; M Mangini; I De Bernardi; F Fontana; G Dionigi; S Cuffari; A Imperatori; D Laganà; C Fugazzola
Journal:  Radiol Med       Date:  2010-03-29       Impact factor: 3.469

4.  Radiofrequency ablation of primary and metastatic lung tumors: preliminary experience with a single center device.

Authors:  D Laganà; G Carrafiello; M Mangini; L Boni; G Dionigi; M C Fusi; L Cinquepalmi; F Rovera; S Cuffari; C Fugazzola
Journal:  Surg Endosc       Date:  2006-07-20       Impact factor: 4.584

Review 5.  Microwave ablation: principles and applications.

Authors:  Caroline J Simon; Damian E Dupuy; William W Mayo-Smith
Journal:  Radiographics       Date:  2005-10       Impact factor: 5.333

6.  Radiofrequency ablation followed by conventional radiotherapy for medically inoperable stage I non-small cell lung cancer.

Authors:  Damian E Dupuy; Thomas DiPetrillo; Sachin Gandhi; Neal Ready; Thomas Ng; Walter Donat; William W Mayo-Smith
Journal:  Chest       Date:  2006-03       Impact factor: 9.410

7.  Race and sex differences in the receipt of timely and appropriate lung cancer treatment.

Authors:  Lisa R Shugarman; Katherine Mack; Melony E S Sorbero; Haijun Tian; Arvind K Jain; J Scott Ashwood; Steven M Asch
Journal:  Med Care       Date:  2009-07       Impact factor: 2.983

8.  Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients.

Authors:  Caroline J Simon; Damian E Dupuy; Thomas A DiPetrillo; Howard P Safran; C Alexander Grieco; Thomas Ng; William W Mayo-Smith
Journal:  Radiology       Date:  2007-04       Impact factor: 11.105

9.  Microwave ablation of lung malignancies: effectiveness, CT findings, and safety in 50 patients.

Authors:  Farrah J Wolf; David J Grand; Jason T Machan; Thomas A Dipetrillo; William W Mayo-Smith; Damian E Dupuy
Journal:  Radiology       Date:  2008-03-27       Impact factor: 11.105

10.  Radiofrequency ablation for the treatment of stage I non-small cell lung cancer in high-risk patients.

Authors:  Arjun Pennathur; James D Luketich; Ghulam Abbas; Mang Chen; Hiran C Fernando; William E Gooding; Matthew J Schuchert; Sebastien Gilbert; Neil A Christie; Rodney J Landreneau
Journal:  J Thorac Cardiovasc Surg       Date:  2007-08-29       Impact factor: 5.209

View more
  2 in total

Review 1.  The role of percutaneous image-guided ablation for lung tumors.

Authors:  Elena N Petre; Stephen B Solomon; Constantinos T Sofocleous
Journal:  Radiol Med       Date:  2014-07-01       Impact factor: 3.469

2.  Microwave ablation for lung cancer patients with a single lung: Clinical evaluation of 11 cases.

Authors:  Xia Yang; Xin Ye; Licheng Zhang; Dianzhong Geng; Zhenli Du; Guohua Yu; Haipeng Ren; Jiao Wang; Guanghui Huang; Zhigang Wei; Yang Ni; Wenhong Li; Xiaoying Han
Journal:  Thorac Cancer       Date:  2018-03-12       Impact factor: 3.500

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.